NervGen Pharma (TSXV:NGEN) Other Long Term Assets : C$0.00 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma Other Long Term Assets?

NervGen Pharma's other long-term assets for the quarter that ended in Mar. 2025 was C$0.00 Mil.

NervGen Pharma's quarterly other long-term assets declined from Sep. 2024 (C$0.03 Mil) to Dec. 2024 (C$-0.00 Mil) but then increased from Dec. 2024 (C$-0.00 Mil) to Mar. 2025 (C$0.00 Mil).

NervGen Pharma's annual other long-term assets increased from Dec. 2022 (C$-0.00 Mil) to Dec. 2023 (C$0.00 Mil) but then declined from Dec. 2023 (C$0.00 Mil) to Dec. 2024 (C$-0.00 Mil).

NervGen Pharma Other Long Term Assets Historical Data

The historical data trend for NervGen Pharma's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma Other Long Term Assets Chart

NervGen Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

NervGen Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															-	0.06	0.03	-	-

NervGen Pharma Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

NervGen Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (TSXV:NGEN) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NGENF:USA 9UA:Germany

Address

112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4

Website

https://www.nervgen.com

NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.

Executives

John Ruffolo	Director
Krista Mckerracher	Director
William Joseph Radvak	Director
Harold Punnett	10% Security Holder, Director
Robert Pilz	Senior Officer

NervGen Pharma Headlines

No Headlines